Cyclin-dependent kinase inhibitors: efficacy and safety
Breast Cancer is the most common type of cancer worldwide. Scientific advances and new ways of treating have significantly improved the prognosis of breast cancer in recent decades. The emergence of modern cyclin-dependent kinase (CDK) inhibitors has changed the treatment paradigm for metastatic hor...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Remedium Group LLC
2019-06-01
|
| Serija: | Медицинский совет |
| Teme: | |
| Online dostop: | https://www.med-sovet.pro/jour/article/view/3052 |
| Oznake: |
Brez oznak, prvi označite!
|